MicroPort Hong Kong Public Offering 224 Times Oversubscribed

HONG KONG, 21 September 2010--MicroPort Scientific Corporation ("MicroPort" or "the Company"), a leading developer, manufacturer and marketer of medical devices in China minimally invasive interventional products for the treatment of vascular diseases and disorders, has received more than 224 times oversubscription in the Hong Kong Public Offering. The offer price of its Global Offering has been set at HK$6.10 per share, the top end of the indicative price range. The amount of the net proceeds from the Global Offering before exercise of the over- allotment option is approximately HK$1,428.3 million.